开云app官网登录入口网页版-官方正版

#慢性丙肝#

19篇内容 | 1031人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1632266, encodeId=13dc163226655, content=<a href='/topic/show?id=ef7f53453c0' target=_blank style='color:#2F92EE;'>#慢性丙肝#</a>, objectTitle=吉利德全新慢性丙肝药物“吉三代”沃士韦在中国上市，10万以内搞定丙肝, objectType=article, longId=197037, objectId=381719e037b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=381719e037b2, replyNumber=0, likeNumber=59, createdTime=2021-03-17, rootId=0, userName=sunylz, userId=305521881489, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=381719e037b2, moduleTitle=吉利德全新慢性丙肝药物“吉三代”沃士韦在中国上市，10万以内搞定丙肝, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=381719e037b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632265, encodeId=591316322650f, content=<a href='/topic/show?id=ef7f53453c0' target=_blank style='color:#2F92EE;'>#慢性丙肝#</a>, objectTitle=J Gastroenterol Hepatol：在慢性丙肝患者中，血清冷球蛋白血症与肝活检患者的晚期纤维化，显著相关, objectType=article, longId=138477, objectId=44bd1384e702, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44bd1384e702, replyNumber=0, likeNumber=73, createdTime=2018-05-25, rootId=0, userName=sunylz, userId=305521881489, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44bd1384e702, moduleTitle=J Gastroenterol Hepatol：在慢性丙肝患者中，血清冷球蛋白血症与肝活检患者的晚期纤维化，显著相关, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=44bd1384e702)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632264, encodeId=43ff163226433, content=<a href='/topic/show?id=ef7f53453c0' target=_blank style='color:#2F92EE;'>#慢性丙肝#</a>, objectTitle=2017 ESPGHAN意见书：儿童慢性丙肝感染的治疗, objectType=article, longId=125760, objectId=b5d5125e6054, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5d5125e6054, replyNumber=0, likeNumber=64, createdTime=2018-08-15, rootId=0, userName=sunylz, userId=305521881489, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5d5125e6054, moduleTitle=2017 ESPGHAN意见书：儿童慢性丙肝感染的治疗, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=b5d5125e6054)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632262, encodeId=cfb9163226256, content=<a href='/topic/show?id=ef7f53453c0' target=_blank style='color:#2F92EE;'>#慢性丙肝#</a>, objectTitle=J Hepatol:使用和未使用IFN的慢性丙肝患者HCC早期发生和复发风险竟然相似！, objectType=article, longId=121695, objectId=c56112169563, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c56112169563, replyNumber=0, likeNumber=62, createdTime=2018-03-29, rootId=0, userName=sunylz, userId=305521881489, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c56112169563, moduleTitle=J Hepatol:使用和未使用IFN的慢性丙肝患者HCC早期发生和复发风险竟然相似！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=c56112169563)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632263, encodeId=d6a81632263aa, content=<a href='/topic/show?id=ef7f53453c0' target=_blank style='color:#2F92EE;'>#慢性丙肝#</a>, objectTitle=艾伯维旗下维建乐®（奥比帕利片）联合易奇瑞®（达塞布韦钠片）治疗方案在华获批用于治疗基因1型慢性丙肝, objectType=article, longId=122564, objectId=3ffa12256425, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ffa12256425, replyNumber=0, likeNumber=64, createdTime=2018-09-04, rootId=0, userName=sunylz, userId=305521881489, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ffa12256425, moduleTitle=艾伯维旗下维建乐®（奥比帕利片）联合易奇瑞®（达塞布韦钠片）治疗方案在华获批用于治疗基因1型慢性丙肝, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=3ffa12256425)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632261, encodeId=efc8163226125, content=<a href='/topic/show?id=ef7f53453c0' target=_blank style='color:#2F92EE;'>#慢性丙肝#</a>, objectTitle=Gut Liver：慢性丙肝合并血友病患者直接抗病毒治疗的效果较好, objectType=article, longId=114535, objectId=431b11453529, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=431b11453529, replyNumber=0, likeNumber=57, createdTime=2018-04-01, rootId=0, userName=sunylz, userId=305521881489, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=431b11453529, moduleTitle=Gut Liver：慢性丙肝合并血友病患者直接抗病毒治疗的效果较好, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=431b11453529)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632260, encodeId=bf0416322601f, content=<a href='/topic/show?id=ef7f53453c0' target=_blank style='color:#2F92EE;'>#慢性丙肝#</a>, objectTitle=遇见这样的慢性丙肝，如何是好？, objectType=article, longId=69348, objectId=30966934847, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=30966934847, replyNumber=0, likeNumber=60, createdTime=2017-03-24, rootId=0, userName=sunylz, userId=305521881489, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=30966934847, moduleTitle=遇见这样的慢性丙肝，如何是好？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=30966934847)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632259, encodeId=1d0f16322594b, content=<a href='/topic/show?id=ef7f53453c0' target=_blank style='color:#2F92EE;'>#慢性丙肝#</a>, objectTitle=招募患者：索非布韦联合利巴韦林（±干扰素）治疗慢性丙肝的III期临床研究, objectType=article, longId=56009, objectId=dfa856009e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dfa856009e2, replyNumber=0, likeNumber=78, createdTime=2016-02-05, rootId=0, userName=sunylz, userId=305521881489, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dfa856009e2, moduleTitle=招募患者：索非布韦联合利巴韦林（±干扰素）治疗慢性丙肝的III期临床研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=dfa856009e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632258, encodeId=ca5f16322586c, content=<a href='/topic/show?id=ef7f53453c0' target=_blank style='color:#2F92EE;'>#慢性丙肝#</a>, objectTitle=AIM：Grazoprevir-Elbasvir联合对慢性丙肝（HCV）治疗抵抗患者有显著效果, objectType=article, longId=49877, objectId=9697498e729, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9697498e729, replyNumber=0, likeNumber=77, createdTime=2015-06-10, rootId=0, userName=sunylz, userId=305521881489, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9697498e729, moduleTitle=AIM：Grazoprevir-Elbasvir联合对慢性丙肝（HCV）治疗抵抗患者有显著效果, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=9697498e729)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632257, encodeId=9809163225ed9, content=<a href='/topic/show?id=ef7f53453c0' target=_blank style='color:#2F92EE;'>#慢性丙肝#</a>, objectTitle=Lancet：多药联用治疗慢性丙肝, objectType=article, longId=48968, objectId=a115489686f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a115489686f, replyNumber=0, likeNumber=68, createdTime=2015-06-21, rootId=0, userName=sunylz, userId=305521881489, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a115489686f, moduleTitle=Lancet：多药联用治疗慢性丙肝, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a115489686f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632256, encodeId=f1da16322568b, content=<a href='/topic/show?id=ef7f53453c0' target=_blank style='color:#2F92EE;'>#慢性丙肝#</a>, objectTitle=Gastroenterology：MK-5172、聚乙二醇干扰素α-2a和病毒唑联合给药对首次接受治疗的慢性丙肝患者有效, objectType=article, longId=42340, objectId=325142340b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=325142340b2, replyNumber=0, likeNumber=98, createdTime=2015-04-20, rootId=0, userName=sunylz, userId=305521881489, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=325142340b2, moduleTitle=Gastroenterology：MK-5172、聚乙二醇干扰素α-2a和病毒唑联合给药对首次接受治疗的慢性丙肝患者有效, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=325142340b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632255, encodeId=e356163225563, content=<a href='/topic/show?id=ef7f53453c0' target=_blank style='color:#2F92EE;'>#慢性丙肝#</a>, objectTitle=Gastroenterology ：利巴韦林剂量降低可以安全有效治疗慢性丙肝病毒感染患者博赛泼维相关的贫血, objectType=article, longId=27422, objectId=14ff2e422f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=14ff2e422f7, replyNumber=0, likeNumber=67, createdTime=2014-07-08, rootId=0, userName=sunylz, userId=305521881489, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=14ff2e422f7, moduleTitle=Gastroenterology ：利巴韦林剂量降低可以安全有效治疗慢性丙肝病毒感染患者博赛泼维相关的贫血, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=14ff2e422f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632254, encodeId=bd62163225419, content=<a href='/topic/show?id=ef7f53453c0' target=_blank style='color:#2F92EE;'>#慢性丙肝#</a>, objectTitle=J HEPATOL：多学科支持计划提高慢性丙肝患者依从性及抗病毒治疗有效性, objectType=article, longId=21197, objectId=26e92119eeb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26e92119eeb, replyNumber=0, likeNumber=60, createdTime=2013-12-28, rootId=0, userName=sunylz, userId=305521881489, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26e92119eeb, moduleTitle=J HEPATOL：多学科支持计划提高慢性丙肝患者依从性及抗病毒治疗有效性, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=26e92119eeb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632253, encodeId=7dc1163225340, content=<a href='/topic/show?id=ef7f53453c0' target=_blank style='color:#2F92EE;'>#慢性丙肝#</a>, objectTitle=JH：根据慢性丙肝患者肌苷三磷酸酶基因多态性可预测严重贫血的发生, objectType=article, longId=19765, objectId=588919e65a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=588919e65a6, replyNumber=0, likeNumber=74, createdTime=2013-09-14, rootId=0, userName=sunylz, userId=305521881489, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=588919e65a6, moduleTitle=JH：根据慢性丙肝患者肌苷三磷酸酶基因多态性可预测严重贫血的发生, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=588919e65a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632251, encodeId=cda716322519b, content=<a href='/topic/show?id=ef7f53453c0' target=_blank style='color:#2F92EE;'>#慢性丙肝#</a>, objectTitle=Clin Infect Dis：血清标志物FIB-4或可用于慢性丙肝纤维化分期, objectType=article, longId=17784, objectId=b5c01e78457, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5c01e78457, replyNumber=0, likeNumber=64, createdTime=2013-12-08, rootId=0, userName=sunylz, userId=305521881489, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5c01e78457, moduleTitle=Clin Infect Dis：血清标志物FIB-4或可用于慢性丙肝纤维化分期, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=b5c01e78457)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632250, encodeId=69b7163225076, content=<a href='/topic/show?id=ef7f53453c0' target=_blank style='color:#2F92EE;'>#慢性丙肝#</a>, objectTitle=JAMA：持续病毒学应答或增慢性丙肝患者存活率, objectType=article, longId=14066, objectId=8e4b14066b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e4b14066b9, replyNumber=0, likeNumber=82, createdTime=2013-08-29, rootId=0, userName=sunylz, userId=305521881489, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e4b14066b9, moduleTitle=JAMA：持续病毒学应答或增慢性丙肝患者存活率, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=8e4b14066b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632252, encodeId=34d31632252ed, content=<a href='/topic/show?id=ef7f53453c0' target=_blank style='color:#2F92EE;'>#慢性丙肝#</a>, objectTitle=NEJM：Sofosbuvir用于慢性丙肝病毒感染初治安全有效, objectType=article, longId=17873, objectId=869b1e8730e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=869b1e8730e, replyNumber=0, likeNumber=75, createdTime=2013-07-14, rootId=0, userName=sunylz, userId=305521881489, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=869b1e8730e, moduleTitle=NEJM：Sofosbuvir用于慢性丙肝病毒感染初治安全有效, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=869b1e8730e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632249, encodeId=35741632249ca, content=<a href='/topic/show?id=ef7f53453c0' target=_blank style='color:#2F92EE;'>#慢性丙肝#</a>, objectTitle=中日对比：PEG IFN治疗慢性丙肝的疗效很大化, objectType=article, longId=7530, objectId=f404e53062, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f404e53062, replyNumber=0, likeNumber=88, createdTime=2012-10-30, rootId=0, userName=sunylz, userId=305521881489, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f404e53062, moduleTitle=中日对比：PEG IFN治疗慢性丙肝的疗效很大化, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=f404e53062)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632248, encodeId=215a163224810, content=<a href='/topic/show?id=ef7f53453c0' target=_blank style='color:#2F92EE;'>#慢性丙肝#</a>, objectTitle=综述：慢性丙肝患者的规范化治疗, objectType=article, longId=6396, objectId=a17663960e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a17663960e, replyNumber=0, likeNumber=76, createdTime=2012-09-07, rootId=0, userName=sunylz, userId=305521881489, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a17663960e, moduleTitle=综述：慢性丙肝患者的规范化治疗, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a17663960e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

慢性丙肝

2020-05-29

sunylz (审核中...)

前往app查看评论内容

#慢性丙肝#

吉利德全新慢性丙肝药物“吉三代”沃士韦在中国上市，10万以内搞定丙肝

2021-03-17

sunylz (审核中...)

前往app查看评论内容

#慢性丙肝#

J Gastroenterol Hepatol：在慢性丙肝患者中，血清冷球蛋白血症与肝活检患者的晚期纤维化，显著相关

2018-05-25

sunylz (审核中...)

前往app查看评论内容

#慢性丙肝#

2017 ESPGHAN意见书：儿童慢性丙肝感染的治疗

2018-08-15

sunylz (审核中...)

前往app查看评论内容

#慢性丙肝#

J Hepatol:使用和未使用IFN的慢性丙肝患者HCC早期发生和复发风险竟然相似！

2018-03-29

sunylz (审核中...)

前往app查看评论内容

#慢性丙肝#

艾伯维旗下维建乐®（奥比帕利片）联合易奇瑞®（达塞布韦钠片）治疗方案在华获批用于治疗基因1型慢性丙肝

2018-09-04

sunylz (审核中...)

前往app查看评论内容

#慢性丙肝#

Gut Liver：慢性丙肝合并血友病患者直接抗病毒治疗的效果较好

2018-04-01

sunylz (审核中...)

前往app查看评论内容

#慢性丙肝#

遇见这样的慢性丙肝，如何是好？

2017-03-24

sunylz (审核中...)

前往app查看评论内容

#慢性丙肝#

招募患者：索非布韦联合利巴韦林（±干扰素）治疗慢性丙肝的III期临床研究

2016-02-05

sunylz (审核中...)

前往app查看评论内容

#慢性丙肝#

AIM：Grazoprevir-Elbasvir联合对慢性丙肝（HCV）治疗抵抗患者有显著效果

2015-06-10

sunylz (审核中...)

前往app查看评论内容

#慢性丙肝#

Lancet：多药联用治疗慢性丙肝

2015-06-21

sunylz (审核中...)

前往app查看评论内容

#慢性丙肝#

Gastroenterology：MK-5172、聚乙二醇干扰素α-2a和病毒唑联合给药对首次接受治疗的慢性丙肝患者有效

2015-04-20

sunylz (审核中...)

前往app查看评论内容

#慢性丙肝#

Gastroenterology ：利巴韦林剂量降低可以安全有效治疗慢性丙肝病毒感染患者博赛泼维相关的贫血

2014-07-08

sunylz (审核中...)

前往app查看评论内容

#慢性丙肝#

J HEPATOL：多学科支持计划提高慢性丙肝患者依从性及抗病毒治疗有效性

2013-12-28

sunylz (审核中...)

前往app查看评论内容

#慢性丙肝#

JH：根据慢性丙肝患者肌苷三磷酸酶基因多态性可预测严重贫血的发生

2013-09-14

sunylz (审核中...)

前往app查看评论内容

#慢性丙肝#

Clin Infect Dis：血清标志物FIB-4或可用于慢性丙肝纤维化分期

2013-12-08

sunylz (审核中...)

前往app查看评论内容

#慢性丙肝#

JAMA：持续病毒学应答或增慢性丙肝患者存活率

2013-08-29

sunylz (审核中...)

前往app查看评论内容

#慢性丙肝#

NEJM：Sofosbuvir用于慢性丙肝病毒感染初治安全有效

2013-07-14

sunylz (审核中...)

前往app查看评论内容

#慢性丙肝#

中日对比：PEG IFN治疗慢性丙肝的疗效很大化

2012-10-30

sunylz (审核中...)

前往app查看评论内容

#慢性丙肝#

综述：慢性丙肝患者的规范化治疗

2012-09-07

科室
- - 订阅+
  - 更多科室
工具
服务